BIFIDO Co., Ltd. sell "BGN4_Raw Material"

Bifidobacterium bifidum BGN4, isolated from the feces of healthy breastfed infants, holds US FDA GRAS status (GRN 814, NDI 1079), is deposited at the KCCM (KCCM 80046), and is patented with completed NGS sequencing. Research links it to gut benefits (immune support, diarrhea, ulcerative colitis, IBS), brain effects (cognitive function, mood), kidney protection (acute kidney injury) and skin benefits (eczema).